Delivery Order SPE2DB22D1103-SPE2DB23FE3XQ
Award Date
5/12/23
Potential Completion Date
5/15/23
Potential Value
$1.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, by the Defense Logistics Agency (DLA). The $2,167.52 firm-fixed-price delivery order is for the supply of 4,564,389,827 units of 360 mg mycophenolic acid delayed-release tablets. The award is not associated with a set-aside program. Amerisourcebergen holds a $999,999,999.00 single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award, valued at $26,859.77, is for the delivery of Mycophenolic Acid DR 180 mg tablets in quantities of 120 per bottle. The contract is a firm fixed-price Delivery Order with an ultimate completion date of October 12, 2023. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a Delivery Order valued at $1,535.60 with a Firm Fixed Price pricing type and an ultimate completion date of September 28, 2023. The contract is for the delivery of Mycophenolic Acid delayed-release tablets, 360mg, in quantities of 120s. This pharmaceutical product is likely used to support military...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of mycophenolate 500 mg tablets. The contract has a ceiling value of $1,832.60 and a period of performance through August 5, 2024. The contract is a delivery order and utilizes a firm fixed-price pricing type. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for Mycophenolic Acid DR 360 mg tablets, 120 count, with a ceiling value of $5,956.03 and a completion date of April 27, 2023. The contract is a Firm Fixed Price arrangement and was not set aside for any specific business type. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,364.70 firm fixed-price delivery order is for Mycophenolate 500 mg tablets, a specialty medication. The contract has a ceiling value of $1,364.70 and an ultimate completion date of February 12, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The award, a firm fixed price delivery order, is for the supply of Mycophenolate 500 mg tablets. The contract has a ceiling value of $2,073.55 and a period of performance through April 3, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,124.48 firm fixed-price delivery order is for the supply of 4,567,151 units of the medication Mycophenolate 500 mg tablets. The contract has an ultimate completion date of February 5, 2025 and is not designated under any set-aside program. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award, valued at $6,776.92, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Mycophenolate 200 mg/ml suspension, a pharmaceutical product, with a completion date of December 5, 2023. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. The award was made through full and open competition, as there was no set-aside designation....
This federal contract award is for the delivery of Mycophenolate 200 mg/mL suspension, a pharmaceutical product, to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The award, valued at $14,388.76, was made to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, through a Delivery Order under an Indefinite Delivery Contract (IDC) held by its parent company, Cencora, Inc. The IDC with the DLA Troop Support Medical, valued at up to...